Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
Low dose mepolizumab as steroid sparing strategy in HES remission phase
HTML
Details
Locations
Year:
2023
Type:
article
Source:
Journal of Allergy and Clinical Immunology
DOI:
10.1016/j.jaci.2022.12.351
Authors:
Matteo Maule,
Gianenrico Senna,
Veronica Batani,
Federica Maiolini,
Simonetta Friso,
Marco Caminati
show all 6
Institutions:
University of Verona,
Azienda Ospedaliera Universitaria Integrata Verona
Language:
English
Topic:
Eosinophilic Disorders and Syndromes
Subfield:
Rheumatology
Field:
Medicine
Domain:
Health Sciences
Keywords:
mepolizumab,
hypereosinophilic syndrome,
steroid-sparing therapy,
remission duration,
anti-IL-4 receptor therapy,
eosinophilic disorders
show all 6
SDG:
Good health and well-being
Open Access status:
closed
OpenAlex ID:
W4319082784
FWCI:
0.333
Cites:
Cited by:
2
Related to:
10